August 6-9, 2024
Virginia Beach, VA CME Conference
Register Now!
*visitVirginiaBeach.com
Daily Schedule anchor
Daily Schedule For Virginia Beach, VA CME Conference
Whether you practice full-time and strive to sharpen your skills, or you work occasionally and need to improve your knowledge base, there’s something for everyone here! Perhaps you just want to stay current and pass your recertification exams. Plus, this exciting program allows participants to come early and/or stay over the weekend for a vacation. Discounted hotel rates apply! Schedule is preliminary.
Topics, times and presenters subject to change.
Product Theater (Non-CME) denoted by *
*Number of hours depends on your course selection. Rx denotes Pharmacology hours. Daily CME credits listed are the maximum number of credits available for that specific day.
Monday, August 5 – Early Registration 2:00 – 5:00 pm
- August 6
Day 1 – Tuesday
Dermatology - August 7
Day 2 – Wednesday
Orthopedics - August 8
Day 3 – Thursday
Cardiology & Emergency Medicine - August 9
Day 4 – Friday
Women’s Health
Kristin Rygg, PA-C
6:30 – 8:00 AM
Registration & Breakfast
7:30 – 8:30 AM
Red and Bumpy and Dry Oh My! (Rx=0.50)
What’s on their face? What to do when it’s not just acne. This session will cover the diagnosis and treatment of frequently seen facial conditions, including acne, rosacea, cysts, and facial dermatosis. In addition, pityriasis alba, perioral, lid, lip, and seborrheic dermatitis will also be reviewed.
8:30 – 9:30 AM
It’s Not Just a Base Tan
What are the long-term consequences of baby oil, tanning beds, and a lack of SPF? You guessed it…skin cancer! It’s the most common cancer in the US, and statistics show that 1 in 5 will develop skin cancer in their lifetime. This session will look at the most common skin cancers, and a few must not miss diagnoses. We’ll review actinic keratosis, BCC/SCC, Melanoma, Extramammary Paget disease, and CTCL.
9:30 – 9:45 AM
Break
9:45 – 11:15 AM
But, Is It Contagious? (Rx=0.50)
Contagious or not?! Does your patient need to avoid friends, family, or sexual partners? This session will look at common skin conditions patients present with and frequently wonder if they are contagious. Pityriasis Rosea, Condyloma, Zoster, Herpes, Hidradenitis Suppurativa, and plant dermatitis will be reviewed.
11:15 AM – 12:30 PM
Sponsored Lunch or Lunch on Your Own
12:30 – 2:00 PM
I’ll Take Spots for 400
This session will look at common and not-so-common skin spots to help aid you in their diagnosis, treatment and refer to dermatology as warranted. This lecture will focus on identifying and treating benign lesions, including hemangiomas, SKs, LPLKs, Molluscum, Warts, Nevi, acrochordons, café o lait, and blue nevi.
2:00 – 2:15 PM
Break
2:15 – 3:45 PM
Let’s Make a Rash Decision (Rx=0.50)
It’s Friday at five, and your patient is red and itchy. What do you do? When, what, and where do you put that steroid? This session will look at the diagnosis and treatment of several common rashes and skin conditions to help relieve your patient and get you to happy hour on time. This session will include irritant and allergic contact dermatitis, eczema, psoriasis, tinea infection, scabies, drug eruptions, and life-threatening rashes. We will also review the basics of steroid use, including what, when, and where to use it.
Gerald Weniger, PhD, ATC, PA-C
6:30 – 8:00 AM
Registration & Breakfast
7:30 – 8:30 AM
Knock Their Socks Off: Foot & Ankle Pathologies You May Be Missing
Most clinicians are likely familiar with the evaluation and treatment of common conditions like planter fasciitis, lateral ankle sprains, and Achilles tendinitis. But what about more obscure foot and ankle pathologies? This presentation will review less common musculoskeletal conditions of the foot and ankle such as Morton’s neuroma, Lisfranc injuries, Achilles tendon rupture, and syndesmosis (high ankle) sprains. Often neglected principles for treating inflammation will also be covered.
8:30 – 9:30 AM
All Hands on Deck: Atypical Hand, Wrist, & Finger Injuries
Most clinicians are familiar with the evaluation and treatment of common hand and wrist conditions like carpal tunnel syndrome, wrist sprains, and trigger finger. But what about more obscure pathologies? This presentation will review less common musculoskeletal conditions of the hand and wrist such as Keinbock’s disease, mallet finger, jersey finger, skier’s thumb, UCL tears, and more.
9:30 – 9:45 AM
Break
9:45 – 11:15 AM
A Shoulder to Lean On: Simplifying Evaluation of Common Shoulder Problems
Many clinicians are comfortable with evaluation of musculoskeletal conditions of the hand, wrist, foot, or ankle. But for some reason, evaluation of shoulder pain is often more daunting. SLAP tears? Hawkins-Kennedy test? Bankart tears? O’Brien’s test? This presentation will help you make sense of all the orthopedic acronyms and eponyms so that you can more confidently evaluate a patient with shoulder pain. Useful special tests will be explained and demonstrated.
11:15 AM – 12:30 PM
Sponsored Lunch or Lunch on Your Own
12:30 – 2:00 PM
Everything You “Kneed” to Know: Making Physical Exam of the Knee More Clear
Evaluation of the knee has changed and evolved over the years. Do you perform a Lachman’s test or anterior drawer? Is McMurray’s test still clinically useful? What is a Thessaly test? This presentation will discuss these special tests and more, while making sense of a musculoskeletal exam of the knee. Special attention will be directed towards acute and degenerative meniscus tears, and when referral to orthopedics is prudent.
2:00 – 2:15 PM
Break
2:15 – 3:45 PM
Not the Standard of Care: ED Case Studies in Medical Malpractice
Medical malpractice is any act by a clinician during treatment of a patient that deviates from accepted norms of medical practice and causes injury to the patient. This presentation will review several real-life case study scenarios in orthopedics and emergency medicine. Compartment syndrome? Pulmonary embolus? Oh my! Avoid future pitfalls and potential malpractice claims by learning valuable lessons from prior mistakes.
Margaret Bowers, DNP, FNP-BC, AACC, CHSE, FAANP, FAAN
6:30 – 8:00 AM
Registration & Breakfast
7:30 – 8:30 AM
Making the Most of a Cardiac-Focused Telehealth Visit
In this session, participants will learn how to get the most out of completing a cardiac-focused telehealth visit. Using a case study approach, you will learn how to complete components of a cardiovascular exam in the virtual environment while leveraging technology.
8:30 – 9:30 AM
Hdl, Ldl Cholesterol Oh My! (Rx=0.50)
This session will cover pharmacologic treatments for different components of a lipid panel. Using a case-based approach, we will review treatment options for diverse clinical situations, including patients who are “intolerant/allergic” to specific treatments. Finally, we will discuss various pharmacologic options for treating dyslipidemia.
9:30 – 9:45 AM
Break
9:45 – 11:15 AM
Urgent Cardiac Situations: What Not to Miss!
This session will address urgent cardiac situations that should not be missed in a primary care setting. The discussion will focus on high-risk low volume events such as acute coronary syndrome, spontaneous coronary artery dissection, aneurysms, and hypertensive emergencies. The focus will be on the subtle and not-so-subtle signs and symptoms that may indicate the potential for decompensation.
11:15 AM – 12:30 PM
Sponsored Lunch or Lunch on Your Own
12:30 – 2:00 PM
I Got Rhythm, or Not- Managing Atrial Fibrillation (Rx=0.25)
During this session, you will learn about treatment options for patients with atrial fibrillation. Using a case-based approach, you will learn about pharmacologic strategies for anticoagulation, rate and rhythm control, and when to refer to cardiology for advanced interventions.
2:00 – 2:15 PM
Break
2:15 – 3:45 PM
Replacing “Failure” With “Function” in Heart Failure Management (Rx=0.50)
During this session, you will learn about the latest evidence-based guidelines for managing heart failure with reduced, mildly reduced, and preserved ejection fractions. In addition, the Pharmacokinetics and dynamics of the newest medications will be covered, as well as best practices for titration of guideline-directed medical therapy.
Nancy Berman, MSN, ANP-BC, NCMP, FAANP
6:30 – 8:00 AM
Registration & Breakfast
7:30 – 8:30 AM
Treasure the Bones: Osteoporosis and Fracture Prevention Strategies in Men and Women: Part 1 (Rx=0.50)
This session will introduce a comprehensive approach to the identification of women and men at risk for fracture based on bone densitometry and their 10-year fracture risk using the FRAX calculation. There will be a discussion on who should be screened and then interpretation of results of the bone density and FRAX calculation. There will be discussion of the approach to patients based on whether they are at high or very high risk for fracture. In session part 1, there will be a discussion of the initial workup of patients, non-pharmacologic therapy, and initial therapy of the osteoporotic patient at high risk for fracture with pharmacologic therapy. Treatment of patients at high risk due to therapy such as aromatase inhibitors and androgen deprivation therapy will be discussed. Case studies will be presented for managing osteoporotic patients at high risk for fracture.
8:30 – 9:30 AM
Treasure the Bones: Osteoporosis and Fracture Prevention Strategies in Men and Women: Part 2 (Rx=0.25)
This session will review the approach to patients who are at very high risk for fracture based on their bone density or FRAX calculation. This will include discussion of sequencing of pharmacologic therapy with bone building anabolic agents followed by maintenance with anti-resorptive agents. Current controversies will be discussed including long-term use of bisphosphonates, adverse events including osteonecrosis of the jaw (ONJ) and atypical subtrocanteric femur fractures and drug holidays. Concerns about discontinuation of rank ligand inhibitors and the risk for a rapid increase in vertebral fractures will be discussed. Case studies will be presented for managing osteoporotic patients at very high risk for fracture.
9:30 – 9:45 AM
Break
9:45 – 11:15 AM
Menopause Magic: Learn Tricks for the Management of Women at Midlife and Beyond (Rx=0.50)
This session will provide the attendee with an overview of the menopause transition into the post-menopause with an emphasis on symptom management. There will be an update on guidelines for hormone therapy including issues of long-term use and use after the age of 65. The concept of a window of opportunity for treating women early in the post menopause with less cardiovascular risk than older women will be discussed There will be discussion of FDA approved hormonal and non-hormonal therapy and dietary supplement options for the treatment of hot flashes. There will be a discussion of the identification and treatment of the genito-urinary syndrome of menopause (GSM). Case studies will be utilized to provide clinical management decision-making.
11:15 AM – 12:30 PM
Sponsored Lunch or Lunch on Your Own
12:30 – 2:00 PM
Capture Current Cervical Cancer Prevention Guidelines: New Screening and Risk-Based Management
Cervical cancer prevention has changed significantly in recent years with less frequent screening and the addition of HPV testing as a stand-alone test along with the option for the Pap and HPV test together as cotesting. This session will review the appropriate use of Pap testing, the rationale for HPV testing along with the Pap (co-testing) in women 30 and older and the use of HPV testing as a primary screen (stand-alone test) in women 25 and older by two of the FDA approved HPV tests. There will be a discussion of the new American Cancer Society Guidelines for screening and a review of the new 2019 ASCCP Risk-Based Management Consensus Guidelines for management of abnormal screening and subsequent follow-up with case studies. These guidelines are a shift from results-based to risk-based management relative to the risk of an existing CIN 3 (pre-cancer).
2:00 – 2:15 PM
Break
2:15 – 3:45 PM
Alphabet Soup: AUB and PALM COEIN for Systematic Diagnosis and Management of Abnormal Uterine Bleeding
Abnormal uterine bleeding (AUB) presents due to both structural and non-structural reasons and AUB is a symptom and not a diagnosis. This session will review a systematic approach to the identification and classification of AUB, leading to a diagnosis using the Palm-Coein classification system. This system allows the clinician to assess structural diagnoses including polyps, adenomyosis, leiomyoma, and malignancy. Non-structural diagnoses include coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not yet classified. There will be a review of the appropriate workup and the subsequent options for management of AUB, including both medical and surgical interventions. This will include symptom management and use of newer GnRh antagonists for heavy menstrual bleeding due to fibroids. These agents expand the options for management by the NP and PA in practice before referral to gynecology for possible surgical options including myomectomy, endometrial ablation, and hysterectomy.
Don’t Miss Out On Our Early Deal Specials!
The earlier you register, the more you save!
In-Person Conference
Super Saver
On/Before March 6
$987
Early Bird
On/Before April 6
$1,087
Advance
On/Before July 6
$1,137
Standard
After July 6
$1,157
Bonus!
In-person conferences include FREE virtual access!
Includes a FREE On-demand course by topic! Up to 13 CME hours – a $297 value!
Receive a $100 rebate check when you book 3 nights at our host hotel using our group code!
Virtual Conference Only
Super Saver
On/Before March 6
$827
Advance
On/Before July 6
$877
Standard
After July 6
$927
CME Virtual Conference
Participate in this Live Streaming conference as though you are on-site with us! We have created a CME online experience that puts you right in the conference room. Watch in real-time, ask questions, and network with other live streaming attendees. You can participate in this CME conference from anywhere with a WiFi connection—poolside, hotel lobby, hotel room, or from the convenience of your home or office.
Recordings of the live event will be available for review for three days only, post-conference to all in-person and virtual participants.
